A Randomized, Double-Blind Controlled Trial Evaluating the Effect of Intranasal Insulin on Neurocognitive Function in Euthymic Patients With Bipolar Disorder.
Latest Information Update: 18 Sep 2021
Price :
$35 *
At a glance
- Drugs Insulin (Primary)
- Indications Bipolar I disorders; Bipolar II disorders
- Focus Pharmacodynamics
- 14 Jul 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
- 14 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Jul 2009 Biomarkers information updated